Article
Development of a novel peripherally acting alpha2A-adrenergic receptor antagonist for anti-diabetic
2024-12-23
Abstract excerpt
<h4>Summary</h4> Yohimbine, a potent alpha2A-adrenergic receptor (α 2A AR) antagonist, was found therapeutic potential for type 2 diabetes through improving insulin release. However, the adverse side effects mediated by its actions in the brain hampered its use. Here, based on molecular docking analysis and structural modification, we have developed a novel peripherally acting yohimbine derivative (CDS479-2). Cr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 24dc8fb2-eb0b-5c92-9a07-508195bb42bc
- DOI
- 10.1101/2024.12.17.628818
